Journal Article
Observational Study
Add like
Add dislike
Add to saved papers

A novel cardiovascular death prediction model for Chinese individuals: A prospective cohort study of 381,963 study participants.

Atherosclerosis 2017 September
BACKGROUND AND AIMS: We aimed at developing a novel risk prediction model for death from cardiovascular disease (CVD) for Chinese individuals, based upon a large cohort from Taiwan.

METHODS: This Chinese cohort came from Taiwan, with 381,963 individuals free from CVD, recruited from a private health surveillance program. With a median follow-up of 8.8 years, 1894 CVD deaths out of a total of 10,829 deaths were identified by linking cohort ID with the National Death File.

RESULTS: A novel CVD death risk prediction model for Chinese individuals was established from this cohort. An increase in the resting heart rate was the statistically independent predictor in this model. The discriminatory accuracy was measured by generating the receiver operating characteristic (ROC) curve, and the area under the ROC curve was 0.913 (95% CI = 0.907 to 0.920).

CONCLUSIONS: A novel cardiovascular death prediction model with high predictability for Chinese individuals was demonstrated in the present study.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app